Contraceptive Social Marketing & Large- Scale Product Introduction in

DKT WomanCare’s role in shaping the market for Levoplant in Africa

Presented by: True Overholt, Marketing Director April 8, 2021 DKT WomanCare - Who We Are

A global Sexual & Reproductive Health social marketing company Our primary product categories: • Safe abortion care • Female contraception & SRH We also sell: • Obstetric / gynecological accessories • Clinical training models WomanCare Global History – A few key milestones 1970’s: Ipas created Ipas MVA

2009: WomanCare Global established by Ipas to oversee development of MVA business Old logo of WomanCare Global 2010: WCG expands distribution internationally

July 2017: WomanCare Global Trading becomes part of DKT International

2018: DKT-WCG expands portfolio with Levoplant agreement and global distribution New logo after WomanCare Global became part of DKT International Dec 2018: DKT-WCG sets up HQ & Services company in Paris DKT International 30 Years of Social Marketing for a better life

DKT Impact in 2020 • 48,6 millions of Couple Years of protection (CYPs) • 11,3 million pregnancies averted • 12,8 million unsafe abortions averted • Footprint in 60 market (90+ incl. WomanCare) • 27 Country offices • >248m$ Revenue & support (24,5% from donors)

• In 2020 DKT International sold: • 19.3 million pills of Misoprostol • 5 millions mife/miso combi-packs • 251,000 units of MVA • 1.5 million cannulas • 825 million male and female • 103.5 million OCPs • 16.6 million injectables • 15.9 million ECs • 4 million IUDs Find the imbalance… # of Women, Aged 15-49 # of Women (15-49) with Unmet Need for FP

7% 8%

14% 27% 29% 0% 26%

13%

9% 30% 0% 9% 20% 8%

Central & Southern Eastern & Southeastern Asia Central & Southern Asia Eastern & Southeastern Asia & Carribean Europe & North America Latin America & Carribean Europe & North America Oceania Sub-Saharan Africa Oceania Sub-Saharan Africa Western Asia & North Africa Western Asia & North Africa Unmet Need for FP in Africa Africa has estimated 44 million women with unmet need for (2020)

26% of global unmet need despite only 14% of relevant population

Reasons include: • Too expensive • Lack of appropriate choices • Limited access • Opposition to use • Fear of side effects, etc. How to Increase Contraceptive Use? Respond directly to the barriers based on context… • Too expensive? → Reduce prices

• Lack of appropriate → Introduce more products choices?

• Limited access? → Train more healthcare providers

• Opposition to use and → Educate men and women fear of side effects? about contraception and child spacing In other words… Use Social Marketing!

What is social marketing?

“Social marketing is applying commercial techniques towards socially beneficial objectives” What do social marketers like DKT do? • Register, market, and distribute quality contraceptives • Expand geographic coverage •New countries •New areas within existing countries • Train providers

• Advertise benefits of Sampling condoms to increase contraceptives to create awareness and brand affinity awareness and desire to use …and many other activities Social Marketing through the Supply Chain We do everything to get high-quality sexual and reproductive health products to women all over the world.

Ship goods to Equip healthcare distribution providers with Manufacture/ord partners in more what they need er high-quality than 90+ to deliver SRH SRH products countries services

Obtain product Help distribution Give women the registrations partners deliver power to choose worldwide to more if and when they customers in their want to have a territories child &

A social marketing success story DKT WomanCare & Levoplant: Good for each other, good for the world Levoplant vs. Other Implants: Global Shipments 12 000 000

10 000 000

8 000 000

6 000 000 February 2018: DKT & Dahua agreement 4 000 000 22% 2 000 000 17% 0% 3% 5% 0 2016 2017 2018 2019 2020 Other Implants Levoplant Growing Importance in Key Markets (2020)

Levoplant in Key Markets 1 800 000

1 600 000

1 400 000 30% 1 200 000

1 000 000

800 000 36%

600 000 400 000 78% 35% 57% 200 000

0 Kenya DRC Malawi Madagascar Other Implants Levoplant

These five markets were 42% of global implant demand in 2020 Critical supplier in several markets (2020)

Levoplant: Expanding Access in Markets Big and Small 700 000

600 000

500 000

400 000 78%

300 000 57%

200 000

100 000 67% 67% 0 100% DRC Madagascar Angola Senegal Liberia Other Implants Levoplant Without Levoplant, women would lack access to FP in these markets How did DKT grow demand for Levoplant so quickly? Levoplant success story: Increasing affordability • We reduced price to $6.90 USD Levoplant success story: Increasing availability • We promoted Levoplant to key government agencies, associations, NGOs, and donors Levoplant success story: Increasing availability • We collaborated with governments to include Levoplant in national clinical guidelines and essential medicines lists Levoplant success story: Increasing availability

Canada

Ukraine Kazakhstan Moldova Mongolia

Georgia Kyrgyzstan Azerbaijan

Afghanistan

Pakistan Nepal Mexico Egypt Bangladesh Mauritania Belize Dominican Mali Laos Jamaica Haiti Republic Burkina Niger Sudan Yemen Guatemala Senegal Faso Chad Cambodia Costa Rica Trinidad and Tobago Benin Nigeria Venezuela Sierra Leone South Guyana Cote Togo Panama Ghana Sudan Liberia d’Ivoire Cameroon Colombia Sri Lanka Uganda Kenya Ecuador Gabon Democratic Rwanda Republic of Burundi Peru The Congo Papua New Brazil Guinea Angola We aggressively Zambia Malawi Bolivia Namibia Zimbabwe pursued Botswana Madagascar Chile Paraguay registrations Uruguay leveraging DKT’s Argentina global footprint

Registration Planning to submit Registration Registered Registered not required registration submitted - not DKT WomanCare Levoplant success story: Increasing availability • We trained our distributor partners to promote Levoplant Levoplant success story: Increasing accessibility We trained healthcare providers Top: practical training in Nigeria Bottom left and center: practical training in Belize Bottom right: Participants in Madagascar Levoplant success story: Increasing accessibility • We detailed Levoplant directly to healthcare providers Levoplant success story: Promoting awareness • We promote Levoplant in pharmacies and clinics Levoplant success story: Promoting awareness Promoting Levoplant to women using social media Levoplant success story: Promoting awareness Promoting Levoplant to women using videos

Fifteen videos across five languages Levoplant success story: Driving Hearuptake from some real users of Levoplant: Levoplant success story: Driving uptake The end result is satisfied women using Levoplant! What is next for DKT WomanCare?Maintaining our position is hard work: • Work with Dahua to increase capacity for Levoplant • Introduce Levoplant Dahua factory in Chongming, to new markets • Leverage economies of scale to stabilize the supply chain What is next for DKT WomanCare?We have strong regulatory knowledge, sales/marketing expertise, and distribution network Need high-quality manufacturing partners Key opportunities in Africa: • Injectables • Condoms • Hormonal IUDs • Low-dose / innovative pills • User-controlled methods Email: [email protected] www.dktwomancare.org

WomanCare Global WomanCare Global Trading CIC DKT WomanCare Global Services SAS 1640 Roanoke Blvd One Bartholomew Close, EC1A 7BL 28 Boulevard Haussmann, 75009 Paris Salem, VA 24153 London, UK SIRET: 844400143 Company No. 07231920